anti-CD40 antibody-glucocorticoid conjugate (Jiangsu Hengrui)

N/A

Report date: 2025/06/11 10:45:12

Base Information

Drug Nameanti-CD40 antibody-glucocorticoid conjugate (Jiangsu Hengrui)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitorsGlucocorticoid receptor agonistsImmunosuppressants
TargetsTumor necrosis factor receptor superfamily member 5Glucocorticoid receptor
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A